A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures
- 31 October 1990
- journal article
- research article
- Published by Elsevier BV in Epilepsy Research
- Vol. 7 (2), 136-145
- https://doi.org/10.1016/0920-1211(90)90099-h
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- A randomized double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsyEpilepsy Research, 1990
- Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsyEpilepsy Research, 1989
- Controlled Trial of Lamotrigine (Lamictar) for Refractory Partial SeizuresEpilepsia, 1989
- Seven day administration of lamotrigine in epilepsy: placebocontrolled add-on trialEpilepsy Research, 1987
- Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsyEpilepsy Research, 1987
- Pharmacological Studies on Lamotrigine, A Novel Potential Antiepileptic DrugEpilepsia, 1986
- Pharmacological Studies on Lamotrigine, A Novel Potential Antiepileptic DrugEpilepsia, 1986
- Acute Effects of Lamotrigine (BW430C) in Persons With EpilepsyEpilepsia, 1986
- Alternative single anticonvulsant drug therapy for refractory epilepsyAnnals of Neurology, 1986
- 328. Note: The Use of None-Parametric Methods in the Statistical Analysis of the Two-Period Change-Over DesignPublished by JSTOR ,1972